At a glance
ClinicalIndex Comparison RecordPhase 2Active· 150 enrolled
Drug / intervention
Stereotactic Body Radiation Therapy (SBRT) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase II Protocol Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone
In Brief
A Phase 2 clinical trial evaluating Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Linear Accelerator for Bone Cancer. Active but no longer recruiting, targeting 150 participants across 1 site.
Detailed Summary
This research study is studying a form of radiation therapy called stereotactic body radiation therapy or SBRT as a possible treatment for Cancer that has spread to the spine or other bone
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBone Cancer
CountriesUnited States
Collaborators--
Timeline
Phase 2Active
20172018201920202021202220232024202520262027
First PostedAug 2016
Enrollment StartNov 2016
Primary CompletionMay 2022
TodayJul 2026
Study CompletionMay 2027
First PostedAug 26, 2016
Enrollment StartNov 29, 2016
Primary CompletionMay 1, 2022
Study CompletionMay 1, 2027
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 9.8 years ago
Interventions
Stereotactic Body Radiation Therapy (SBRT)drug
Stereotactic Linear Acceleratordevice